PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Serologic test and its limitation PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global immunohematology market by analyzers and systems • Global immunohematology market by reagents PART 07: Market segmentation by applications • Blood-related diseases • HIV • Hepatitis • PART 08: Market segmentation by end-users • Hospitals • Blood banks • Diagnostic laboratories PART 09: Geographical segmentation • Immunohematology market in Americas • Immunohematology market in EMEA • Immunohematology market in APAC PART 10: Market drivers • Paradigm shift of end-users toward automated immunohematology analyzer • Growing demand for blood banks and its potential to increase sales • Increasing sales through service-oriented sales organizations and GPOs PART 11: Impact of drivers PART 12: Market challenges • High maintenance cost and less reimbursement of blood components • Decrease in blood donors and medical guidelines reducing the sales of immunohematology analyzers • Operational challenge in blood screening and transfusion PART 13: Impact of drivers and challenges PART 14: Market trends • Increasing public and private funding to establish blood banks • Paradigm shift toward molecular immunohematology • Striving market growth through education and training program PART 15: Vendor landscape • Competitive landscape analysis • Geographic presence: Key vendor analysis • Market share analysis • Bio-Rad Laboratories • Grifols • Immucor • Ortho Clinical Diagnostics • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Blood collection and transfusion by hospital services in US 2014 Exhibit 03: Accredited cord blood bank of AABB in various countries Exhibit 04: Market overview: Global immunohematology market Exhibit 05: Impact assessment of global immunohematology market 2015 Exhibit 06: Global immunohematology market 2015-2020 ($ billions) Exhibit 07: Blood products sold in Finland in 2012-2014 Exhibit 08: Global immunohematology market scenarios: Revenue forecast 2015 and 2020 ($ billions) Exhibit 09: Five forces analysis Exhibit 10: Global immunohematology market by product 2015 and 2020 ($ millions) Exhibit 11: Market overview: Global immunohematology market by analyzers and system Exhibit 12: Immunohematology analyzer and system market in 2015-2020 ($ billions) Exhibit 13: Market overview: Global immunohematology market by reagents Exhibit 14: Immunohematology reagents market in 2015-2020 ($ millions) Exhibit 15: Prevalence of cord blood transplantation for cancerous and non-cancerous blood diseases in 2014 Exhibit 16: Market overview: Blood-related diseases in global immunohematology market Exhibit 17: Market overview: HIV in global immunohematology market Exhibit 18: Global immunohematology market by end-users 2015 Exhibit 19: Americas: Country-specific market impact by hospitals Exhibit 20: EMEA: Country-specific market impact by hospitals Exhibit 21: APAC: Country-specific market impact by hospitals Exhibit 22: Americas: Country-specific market impact by blood banks Exhibit 23: EMEA: Country-specific market impact by blood banks Exhibit 24: APAC: Country-specific market impact by blood banks Exhibit 25: Transfusion of blood in different medical segments and their usage percentage in Singapore 2016 Exhibit 26: Global immunohematology market by geographical segmentation: 2015 and 2020 ($ millions) Exhibit 27: Geographical segmentation of global immunohematology market by market share 2015-2020 Exhibit 28: Americas: Market overview of immunohematology Exhibit 29: Americas: Prevalence of blood-borne infections 2013-2014 Exhibit 30: Immunohematology market in Americas 2015-2020 ($ millions) Exhibit 31: Immunohematology market in Americas: Metric analysis for various countries Exhibit 32: Key takeaway: Immunohematology market in US Exhibit 33: EMEA: Market overview of immunohematology Exhibit 34: Number of blood transfusions performed in Europe in 2014 (millions) Exhibit 35: Immunohematology market in Europe 2015-2020 ($ millions) Exhibit 36: Immunohematology market in EMEA: Metric analysis for various countries Exhibit 37: Key takeaway: Immunohematology market in UK Exhibit 38: APAC: Market overview of immunohematology Exhibit 39: Immunohematology market in APAC 2015-2020 ($ millions) Exhibit 40: Immunohematology market in APAC: Metric analysis for various countries Exhibit 41: Key takeaway: Immunohematology market in China Exhibit 42: Market impact: Fully automated immunohematology analyzer based on end-users Exhibit 43: Potential market revenue of immunohematology with estimated number of cord blood units sold worldwide Exhibit 44: Sales strategies of distributors and companies Exhibit 45: Impact of drivers Exhibit 46: Cost of cord blood unit maintenance in private and public blood banks Exhibit 47: Impact of drivers and challenges Exhibit 48: Blood banks: Public-private partnership Exhibit 49: Blood banks: Market impact Exhibit 50: Companies focusing on immunohematology training to promote marketing and sales Exhibit 51: Competitive structure analysis of global immunohematology market 2015 Exhibit 52: Competitive landscape analysis of global immunohematology market 2015 Exhibit 53: Global immunohematology market: Market share analysis of vendors 2015 Exhibit 54: Bio-Rad Laboratories: Profile summary Exhibit 55: Bio-Rad Laboratories: Strength analysis Exhibit 56: Bio-Rad Laboratories: Growth strategy matrix Exhibit 57: Bio-Rad Laboratories: Opportunity assessment Exhibit 58: Grifols: Profile summary Exhibit 59: Grifols: Strength analysis Exhibit 60: Grifols: Growth strategy matrix Exhibit 61: Grifols: Opportunity assessment Exhibit 62: Immucor: Profile summary Exhibit 63: Immucor: Strength analysis Exhibit 64: Immucor: Growth strategy matrix Exhibit 65: Immucor: Opportunity assessment Exhibit 66: Ortho Clinical Diagnostics: Profile summary Exhibit 67: Ortho Clinical Diagnostics: Strength analysis Exhibit 68: Ortho Clinical Diagnostics: Growth strategy matrix Exhibit 69: Ortho Clinical Diagnostics: Opportunity assessment Exhibit 70: Other prominent vendors

Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostics, Agena Bioscience, BD, Beckman Coulter, biosurfit SA, Cardinal Health, DIAGAST, Hemo bioscience, Institut de Biotechnologies Jacques Boy, Lorne Laboratories, MTC INVITRO, Reagens, Seqirus, Tulip, and Quotient.